- Home
- SF vs TECH Comparison
SF vs TECH Comparison
Compare SF & TECH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SF
- TECH
- Stock Information
- Founded
- SF 1890
- TECH 1976
- Country
- SF United States
- TECH United States
- Employees
- SF N/A
- TECH N/A
- Industry
- SF Investment Bankers/Brokers/Service
- TECH Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- SF Finance
- TECH Health Care
- Exchange
- SF Nasdaq
- TECH Nasdaq
- Market Cap
- SF 10.7B
- TECH 12.0B
- IPO Year
- SF N/A
- TECH 1989
- Fundamental
- Price
- SF $113.81
- TECH $75.83
- Analyst Decision
- SF Hold
- TECH Buy
- Analyst Count
- SF 8
- TECH 8
- Target Price
- SF $107.14
- TECH $82.00
- AVG Volume (30 Days)
- SF 714.8K
- TECH 799.7K
- Earning Date
- SF 01-27-2025
- TECH 01-30-2025
- Dividend Yield
- SF 1.48%
- TECH 0.42%
- EPS Growth
- SF 27.32
- TECH N/A
- EPS
- SF 5.54
- TECH 0.95
- Revenue
- SF $4,715,429,000.00
- TECH $1,171,583,000.00
- Revenue This Year
- SF $16.63
- TECH $7.67
- Revenue Next Year
- SF $10.21
- TECH $9.29
- P/E Ratio
- SF $20.56
- TECH $79.87
- Revenue Growth
- SF 9.78
- TECH 2.41
- 52 Week Low
- SF $68.82
- TECH $61.16
- 52 Week High
- SF $119.12
- TECH $85.57
- Technical
- Relative Strength Index (RSI)
- SF 63.35
- TECH 55.66
- Support Level
- SF $102.57
- TECH $73.67
- Resistance Level
- SF $109.74
- TECH $78.44
- Average True Range (ATR)
- SF 2.21
- TECH 2.41
- MACD
- SF 0.83
- TECH 0.28
- Stochastic Oscillator
- SF 97.74
- TECH 66.02
About SF Stifel Financial Corporation
Stifel Financial is a middle-market-focused investment bank that produces more than 90% of its revenue in the United States. Approximately 60% of the company's net revenue is derived from its global wealth management division, which supports over 2,000 financial advisors, with the remainder coming from its institutional securities business. Stifel has a history of being an active acquirer of other financial-services firms.
About TECH Bio-Techne Corp
Based in Minnesota, Bio-Techne is a life sciences manufacturer supplying consumables and instruments for the pharma, biotech, academic, and diagnostic markets. It reports in two segments: protein sciences (75% of revenue) and diagnostics and genomics (25%). The protein sciences segment sells reagents and analytical instruments used in life sciences research, including antibodies used in protein analysis. The diagnostics and genomics segment sells diagnostic reagents, molecular diagnostics, and spatial biology products. The United States accounts for about 55% of revenue. The firm also has operations in Europe, the Middle East, and Africa (20% of sales), the UK (5%), and Asia-Pacific (15%), with the rest of the world accounting for the remaining 5%.